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768Objective: During aortic surgery under hypothermic circulatory arrest, retrograde cerebral perfusion (RCP) is
commonly used as a cerebroprotective method to extend the duration of circulatory arrest safely. Kitahori and
colleagues described a novel protocol of RCP using intermittent pressure augmented (IPA)–RCP in 2005. The
aim of the present study was to determine the clinical effectiveness of this novel protocol.
Methods: A total of 20 consecutive patients undergoing total replacement of the aortic arch were assigned to
a conventional RCP (n ¼ 10) or an IPA-RCP group (n ¼ 10). Cerebral perfusion was provided at a continuous
venous pressure of 25 mm Hg in the conventional RCP, and venous pressure was intermittently provided at 20
mm Hg for 120 seconds and at 45 mm Hg for 30 seconds in the IPA-RCP group. The clinical outcomes were
compared between the 2 groups. Regional cerebral oxygen saturation (rSO2) was measured using near infrared
spectroscopy every 10 minutes from the beginning of RCP initiation. To represent the brain oxygen consump-
tion, the decline ratio of rSO2 was calculated.
Results: There was no surgical mortality or major neurologic complications in either group. The interval from
the end of surgery to full wakefulness was significantly shorter in the IPA-RCP group (85 64 minutes) than in
the conventional RCP group (310  282 minutes; P<.05). Although the initial rSO2 value did not show signif-
icant difference in both groups, the rSO2 with IPA-RCP was greater than that with conventional RCP from 10 to
70 minutes (P<.05). The decline ratio of rSO2 was lower in the IPA-RCP group than in the RCP perfusion group
at all points (P<.05).
Conclusions: IPA-RCPmight provide more homogenous cerebral perfusion and a more effective oxygen supply
to the brain with better clinical results than conventional RCP. (J Thorac Cardiovasc Surg 2013;145:768-73)During aortic surgery under hypothermic circulatory arrest
(HCA), the cerebroprotective method uses retrograde cere-
bral perfusion (RCP) to more safely extend the duration of
HCA. Usui and colleagues1 reported that a venous pressure
of 25 mm Hg was the optimal condition for RCP to avoid
brain injury. However, some reports have suggested that
RCP at a perfusion pressure of less than 25 to 30 mm Hg
provides very limited blood flow to the brain and minimal
or no brain protection. Furthermore, other investigators
have reported that the use of RCP with greater venous pres-
sures results in good outcomes without any significant com-
plications.2,3 Therefore, the optimal method to protect the
brain during HCA remains to be established.
Kitahori and colleagues4 reported a novel method of RCP
(intermittent pressure augmented–retrograde cerebral per-
fusion [IPA-RCP]) that controlled venous pressure at 15e Department of Cardiovascular Surgery, Kyorin University, Tokyo, Japan.
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Hg. These investigators demonstrated the efficacy of this
strategy in an animal model.4
We applied IPA-RCP in clinical cases because cardiopul-
monary bypass (CPB) can be simply driven and the risk of
brain injury did not increase in animal models. We specu-
lated that IPA-RCP could protect the brain more effectively,
because it preserves intracerebral oxygen more completely
by way of intermittent augmented venous pressure than
conventional RCP (cRCP) in clinical cases.
The aim of the present study was to use IPA-RCP in clin-
ical cases and examine the clinical efficacy of IPA-RCP
compared with cRCP.
METHODS
Patients
A total of 20 consecutive patients who underwent total replacement of
the aortic arch with RCP without a concomitant procedure for the manage-
ment of thoracic aortic disease at Kyorin University from January 2005 to
October 2008 were examined. The institutional review board approved the
study, and all patients provided informed consent. Of the 20 patients, 11
were men and 9 were women (average age, 69.6  14.9 years; range,
27–83 years). The thoracic aortic disease consisted of type A acute aortic
dissection in 5 patients and true aortic aneurysm in 15. Surgery was re-
quired on an emergency basis for 6 patients andwas elective for 14 patients.
During the observation period, 46 patients underwent aortic arch surgery at
our institution. Of these, 26, 10, and 10 patients underwent isolated total
replacement of the aortic arch, partial replacement of the aortic arch, andery c March 2013
Abbreviations and Acronyms
cRCP ¼ conventional retrograde cerebral
perfusion
CPB ¼ cardiopulmonary bypass
HCA ¼ hypothermic circulatory arrest
IPA-RCP ¼ intermittent pressure augmented–
retrograde cerebral perfusion
RCP ¼ retrograde cerebral perfusion
rSO2 ¼ regional cerebral oxygen saturation
SVC ¼ superior vena cava
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bypass grafting), respectively. Of those who underwent isolated total re-
placement of the aortic arch, 2 had received a combination of cRCP and
IPA-RCP, and in 4, the regional cerebral oxygen saturation could not be
measured using near-infrared spectroscopy because of noise. These 6 pa-
tients were excluded from the present study. Thus, 20 consecutive patients,
including 10 who had undergone cRCP from 2005 to 2006 and 10 who had
undergone IPA-RCP from 2007 to 2008, were examined (Table 1).
Anesthesia and Surgical Procedures
General anesthesia was performed using total intravenous anesthesia.
Induction was achieved with intravenous midazolam hydrochloride, fen-
tanyl citrate, and vecuronium bromide. The maintenance anesthetic agents
included propofol and fentanyl citrate.
A median sternotomy was performed. Cardiopulmonary bypass (CPB)
was established after the administration of heparin (3 mg/kg). The arterial
cannulation sitewas the femoral artery, and venous cannulas were placed in
the superior vena cava (SVC) and inferior vena cava. The left ventricle was
vented through the right superior pulmonary vein. Surgical tape was placed
around the SVC. Myocardial protection was achieved with antegrade cold
blood cardioplegia.
During perfusion cooling, the pH and partial pressure of carbon dioxide
were maintained by pH-stat principles, at 7.30 to 7.50 for pH and 30 to 50
mm Hg for partial pressure of carbon dioxide, corrected for temperature.
The core temperature was measured by way of a sensor on the tympanic
membrane.
When the core temperature had decreased to 18 to 22C, an open distal
anastomosis was performed using 4-branched prosthetic grafts. The arch
vessels were individually transected, and the left subclavian artery and
left common carotid artery were reconstructed. After reconstruction of
these 2 arch vessels, circulatory arrest and RCP were terminated. The pros-
thetic graft was clamped, and antegrade arterial flow was restarted using
a side branch of the prosthetic graft, resulting in restoration of the normal
core temperature. The innominate artery was reconstructed. Finally, open
proximal anastomosis was performed, and CPBwas weaned. All anesthetic
agents were terminated at the end of surgery, and the patients were trans-
ferred to the intensive care unit.
RCP Protocol
The patients’ temperature was lowered by core cooling. CPB was
stopped after the target temperature was reached, and RCP was started.
In the CPB circuit, the inferior vena cava cannula was clamped, and oxy-
genated blood was perfused into the SVC cannula by way of a recirculation
circuit. Central venous pressure was measured by a catheter inserted to the
SVC.
In the cRCP group, the central venous pressure was provided at 25 mm
Hg. In the IPA-RCP group, the central venous pressure was intermittentlyThe Journal of Thoracic and Caaugmented at 45 mmHg for 30 seconds and decreased to 20mmHg for 120
seconds.
At the end of RCP, the venous pressure was augmented to 40 to 50 mm
Hg for 180 seconds to de-air and flush the debris and switched to antegrade
perfusion using a side branch of the graft.
Cerebral Oxygen Saturation Monitoring
The regional cerebral oxygen saturation (rSO2) was measured using
near-infrared spectroscopy (TOS-96; Tostec, Tokyo, Japan). The TOS-96
consists of a high-performancemicroprocessor controlling unit and a sensor
probe. The sensor probe had 6 light emitting diodes with low-power pulsed
laser lights at wavelengths of 760 and 850 nm and 2 silicon photo diodes.
The sensor probewas applied to the forehead over the frontal lobe lateral to
the midline to avoid the superior sagittal sinus. Real-time spectroscopic
data reflecting the oxyhemoglobin and deoxyhemoglobin levels were con-
tinuously measured. The rSO2 (capillary vessel oxygen consumption in the
cerebral cortex) was calculated using the oxyhemoglobin and deoxyhemo-
globin levels.
Examination Methods
The clinical outcomes were compared between the 2 groups. The clin-
ical outcomes included the following parameters: age, body surface area,
perfusion time, aortic crossclamp time, minimal core temperature, circula-
tory arrest time, RCP time, blood volume loss, blood transfusion, operation
time, anesthetic time, dose of fentanyl citrate and propofol, and interval
from the end of surgery to full wakefulness. The rSO2 was measured every
10 minutes from the initiation of RCP (n¼ 0, 10, 20, 30, 40, 50, 60, 70, 80
minutes). The decline ratio of rSO2 was calculated as follows: [rSO2
(n ¼ 0) rSO2 (n ¼ x minutes)/rSO2 (0)] 3 100%. The rSO2 value and
the decline ratio of rSO2 were compared in both groups.
The primary endpoints were in-hospital death, neurologic complica-
tions, and discharge.
Statistical Analysis
The data were evaluated using SAS, version 5.0 (SAS Institute, Cary,
NC). The results are expressed as the mean  SD. Statistical significance
between the 2 groups was determined using the Mann-Whitney nonpara-
metric test. P<.05 was defined as statistically significant.RESULTS
Clinical Outcomes
The patients in the IPA-RCP group were significantly
younger than those in the cRCP group, mainly because 1 pa-
tient in IPA-RCP group was 27 years old (Table 2). No sig-
nificant difference were found in the anesthetic time or total
dosage of anesthetic agents between the 2 groups. The inter-
val from the end of surgery to full wakefulness was shorter
in the IPA-RCP group than in the cRCP group. No surgical
mortality or major neurologic complications occurred in
either group.rSO2 Value at Each Measurement Point
The initial rSO2 was not significantly different in the 2
groups (Table 3). However, the rSO2 in the IPA-RCP group
was significantly greater than that in the cRCP group when
measured at 10 to 70 minutes. Only 2 patients required IPA-
RCP for longer than 80 minutes, and statistical analysis was
not possible.rdiovascular Surgery c Volume 145, Number 3 769
TABLE 1. Patient characteristics
Characteristic cRCP IPA-RCP P value
Patients (n) 10 10
Age (y) .02
Mean  SD 77.0  5.8 62.2  17.7
Range 68–83 27–81
Body surface area (m2) NS
Mean  SD 1.55  0.14 1.62  0.11
Range 1.25–1.70 1.45–1.81
Gender (n)
Male 6 5
Female 4 5
Preoperative diagnosis (n)
Dissection of aorta 1 4
Thoracic aortic aneurysm 9 6
Timing of surgery (n)
Elective 8 6
Emergency 2 4
cRCP, Conventional retrograde cerebral perfusion; IPA-RCP, intermittent pressure
augmented–retrograde cerebral perfusion; SD, standard deviation;NS, not significant.
TABLE 2. Clinical outcomes
Outcome cRCP IPA-RCP
P
value
Perfusion time (min) NS
Mean  SD 253.7  37.4 220.7  29.8
Range 197–323 191–291
Aortic crossclamp time (min) NS
Mean  SD 132.0  14.1 135.2  17.8
Range 104–158 100–160
Minimal core temperature (C) NS
Mean  SD 15.0  1.0 15.1  1.6
Range 13.4–16.9 12.3–16.8
RCP time (min) NS
Mean  SD 76.4  8.3 68.1  8.0
Range 64–87 55–77
In SVC cannula during RCP*
Hemoglobin (mg/dl) NS
Mean  SD 6.5  0.5 6.9  0.4
Range 6.0–7.4 6.0–7.5
Concentration of oxygen
(mm Hg)
NS
Mean  SD 392.4  35.4 349.6  65.4
Range 346.1–448.7 218.3–435.2
Blood volume loss (mL) NS
Mean  SD 1262.5  831.6 990.3  534.3
Range 570–3173 442–2407
Blood transfusion (U) NS
Mean  SD 10.5  5.6 10.2  8.8
Range 3–20 0–26
Operation time (min) NS
Mean  SD 507  87 455  60
Range 405–672 384–565
Anesthetic time (min) NS
Mean  SD 660  73 572  70
Range 550–799 499–694
Dose of fentanyl citrate (mL) NS
Mean  SD 1080  210 1090  288
Range 900–1600 700–1600
Dose of propofol (mg) NS
Mean  SD 2249  416 2414  638
Range 1365–2801 1455–3447
Interval from surgery end to
full wakefulness (min)
.03
Mean  SD 310  282 85  64
Range 10–785 3–200
Intubation time (min) NS
Mean  SD 1950  1964 1087  903
Range 625–5510 0–2905
ICU stay (d) NS
Mean  SD 12.3  16.2 5.7  1.4
Range 4–55 4–8
Hospital stay (d) .02
Mean  SD 58.5  32.0 30.4  14.1
Range 16–121 19–60
cRCP, Conventional retrograde cerebral perfusion; IPA-RCP, intermittent pressure
augmented–retrograde cerebral perfusion;NS, not significant; SD, standard deviation;
RCP, retrograde cerebral perfusion; SVC, superior vena cava; ICU, intensive care unit.
*At the start of RCP.
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The curve of rSO2 during RCP is illustrated in Figure 1.
In the cRCP group, the rSO2 decreased sharply just the start
of RCP and then gradually decreased until the end of RCP.
In the IPA-RCP group, the rSO2 gradually decreased during
low venous pressure and increased during intermittent aug-
mented venous pressure. In both procedures, the rSO2 curve
decreased sharply just after the resumption of antegrade ce-
rebral perfusion by way of a side branch of the graft, but
then it gradually increased back to its initial level. Thus,
the decline ratio of rSO2 was significantly lower in the
IPA-RCP group than in the cRCP group at each measure-
ment point (Figure 2 and Table 4).
DISCUSSION
RCP was originally described as an emergency treatment
of a massive air embolism during CPB,5 and Ueda and col-
leagues6 characterized the efficacy of RCP during HCA in
1990. The method for RCP was described with the pre-
sumption that a venous pressure of 25 mm Hg was the op-
timal condition for RCP to avoid brain injury,1,7,8 and
thus, RCP has been performed under continuous venous
pressure of 25 mm Hg. However, some investigators have
reported that RCP did not provide neurologic protection
at a venous pressure of less than 25 mm Hg in several
clinical and experimental studies,9-12 and other studies
have indicated that high venous pressure might cause
brain edema.2,13 In contrast, Li and colleagues3 and Estrera
and colleagues2 reported that a venous pressure greater than
30 mm Hg resulted in better tissue oxygenation without tis-
sue edema in an animal model and did not result in brain in-
jury in clinical cases. Thus, it is still unclear whether RCP
with a venous pressure of 25 mm Hg is optimum and pro-
vides appropriate neurologic protection.770 The Journal of Thoracic and Cardiovascular Surgery c March 2013
TABLE 3. rSO2 values
Measurement point (min) cRCP (%) IPA-RCP (%) P value
0 NS
Mean  SD 72.7  6.6 73.1  4.2
Range 62.5–87.5 65.7–80.0
10 .04
Mean  SD 66.5  8.0 70.9  5.0
Range 53.4–82.4 61.3–79.5
20 .02
Mean  SD 63.6  7.7 68.2  5.3
Range 51.1–79.1 58.8–77.2
30 .02
Mean  SD 60.6  8.3 66.7  5.0
Range 46.8–76.0 57.4–77.5
40 .04
Mean  SD 59.1  9.4 65.3  4.9
Range 44.9–75.0 55.2–75.9
50 .04
Mean  SD 57.6  10.5 64.6  4.6
Range 39.2–73.3 56.0–74.6
60 .002
Mean  SD 54.9  10.9 64.7  3.7
Range 33.4–72.9 58.8–73.9
70 .007
Mean  SD 54.3  10.9 63.6  3.9
Range 32.0–72.6 57.3–67.8
80 —
Mean  SD 53.5  11.8 62.9  4.2
Range 30.8–67.8 59.9–65.8
rSO2, Regional cerebral oxygen saturation; cRCP, conventional retrograde cerebral
perfusion; IPA-RCP, intermittent pressure augmented–retrograde cerebral perfusion;
NS, not significant; SD, standard deviation.
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protocol of RCP with intermittent pressure augmentation
and examined the efficacy of this protocol in a canine
model. They reported that cRCP was associated with
a sudden loss of cerebral perfusion pressure with conver-
sion of antegrade to retrograde perfusion, resulting in col-
lapse of the cortical veins and increased resistance to
opening of the cerebrovenous vessels. Further, they
showed that venous pressure of less than 25 mm Hg was
insufficient to promote opening of the cerebral microves-
sels by observing changes in diameters of the retinal ves-
sels. In contrast, a continuously high venous pressure of
RCP was associated with an increased risk of perfusion-
induced brain injury. In their protocol of RCP, the venous
pressure was controlled at 15 mm Hg and was augmented
to 45 mm Hg quickly and then decreased again to the
baseline level of 15 mm Hg as soon as it reached 45
mm Hg every 30 seconds throughout the 60-minute dura-
tion of HCA. They concluded that the RCP pressure was
important to overcome the venous resistance of the capil-
laries and to maintain microvessel patency. Intermittent
high pressure effectively overcame the maldistribution
associated with RCP without brain damage. This novelThe Journal of Thoracic and Camethod might provide effective neurologic protection dur-
ing aortic surgery.4
In the present study, IPA-RCP was applied clinically by
modifying the original experimental protocol. As the first
point of modification, the maximal venous pressure was
the same as that required to open the cerebral microvessels,
and the minimum venous pressure was changed to 20 mm
Hg. The reasons for the modification were that a venous
pressure of 20 mm Hg was reported to provide metabolic
support for the brain.7 The second point of modification
was that the duration of augmented pressure was set at 30
seconds. The original protocol was to decrease the venous
pressure to 15 mm Hg as soon as it had reached 45 mm
Hg. We considered this would result in a burden and
a risk of carelessness because of the complicated and per-
petual CPB driving.
In the present study, the dose of anesthetic agents and
clinical outcomes were similar between the cRCP and
IPA-RCP groups; however, the interval from the end of sur-
gery to full wakefulness was shorter in the IPA-RCP group
than in the cRCP group. Previous animal studies have sug-
gested that IPA-RCP results in good recovery from anesthe-
sia and less neurologic damage compared with cRCP and
HCA.4 The reason for the shorter interval to wakefulness
in the IPA-RCP group might have been related to the mainly
neuroprotective effect provided by the homogeneous cere-
bral perfusion and better oxygen supply.
The efficacy of IPA-RCP was assessed through measure-
ment of frontal lobe rSO2 in the present study. This was
achieved using near-infrared spectroscopy (TOS-96;
Tostec), because most attenuation of near-infrared light in
human cerebral tissues results from absorption by deoxyhe-
moglobin and deoxyhemoglobin.13 The determination of
rSO2 is an easy method to assess the real-time adequacy of
cerebral perfusion during deep hypothermic time-restricted
aortic arch surgery.13,14 However, rSO2 measurements can
vary with temperature, hemoglobin level, oxygenated
blood, and oxygen consumption in the cerebral tissue and
anatomy.15-17 Regardless, no significant difference was
found in the minimal core temperature or the concentration
of oxygen and hemoglobin in the perfused blood to the
SVC during RCP between the cRCP and IPA-RCP groups
in the present study.
The rSO2 curve showed immediate recovery with every
venous pressure augmentation, and it decreased when the
augmentation ceased. Furthermore, the decline ratio of
rSO2 was significantly lower in the IPA-RCP group than
in the cRCP group at each measurement point. The essential
effect of IPA-RCPmight be a temporary increase in cerebral
oxygen saturation and augmentation of the decline ratio of
rSO2 during RCP. These observations support the notion of
the ‘‘bottom raising effect’’ of IPA-RCP described in our
case reports14,18 and can be explained in that a venous
pressure of 45 mm Hg opens up the intracranialrdiovascular Surgery c Volume 145, Number 3 771
FIGURE 1. Typical waveform of regional cerebral oxygen saturation (rSO2)measured by near-infrared spectroscopy during retrograde cerebral perfusion
(RCP) in each group. (Upper) Conventional RCP (cRCP) group. (Lower) Intermittent pressure augmented–retrograde cerebral perfusion (IPA-RCP) group.
A indicates start of hypothermic circulatory arrest (HCA) and RCP; and B, end of HCA and RCP.
Acquired Cardiovascular Disease Endo et al
A
C
Dmicrovessels, allowing perfusion of the peripheral brain
with oxygenated blood, and a venous pressure of 25 mm
Hg was inadequate for cerebral circulation.
The present study had limitations in patients and method.
First, the sample size was rather small, and the study design
was nonrandomized and retrospective. To reduce these lim-
itations and bias, 2 groups of consecutive patients who had
undergone simple total aortic arch replacement were se-
lected and compared. Second, measuring rSO2 using near-
infrared spectroscopy is simple but has the disadvantageFIGURE 2. Serial changes in mean standard deviation decline ratios of
regional cerebral oxygen saturation (rSO2) in conventional retrograde cere-
bral perfusion (cRCP) and intermittent pressure augmented–retrograde ce-
rebral perfusion (IPA-RCP) groups. Solid line, IPA-RCP group; dashed
line, cRCP group. *P<.05.
772 The Journal of Thoracic and Cardiovascular Surgthat flow is measured only in the frontal region. Therefore,
the homogeneity of cerebral blood flow distribution could
not be evaluated. Third, Tau protein and S-100, which are
indicators of cerebrospinal injury, were not measured post-
operatively and the cerebrospinal fluid pressure was not
measured during RCP. The Tau protein levels were signifi-
cantly lower in the IPA-RCP group than in the cRCP group
in an animal model, and the cerebrospinal fluid pressure did
not significantly differ between the 2 groups.4 An additional
clinical study is needed. Fourth, the actual cerebral micro-
circulation was not evaluated because the retinal vessels
were not observed. Experimental studies have demonstrated
that 45 mmHg of venous pressure is required to maintained
patency of the retinal veins and arteries.4,19 Observing the
retinal vessels during IPA-RCP will provide more informa-
tion to recognize the mechanism of brain protection clini-
cally. Fifth, preoperative and postoperative cognitive
functions were not assessed as clinical outcomes. Several
reports have indicated that the incidence of transient brain
dysfunction is significantly greater in patients after
RCP.20,21 The present study was preliminary; thus, more
extensive clinical experience is essential, and additional
analysis of these parameters will help to verify the
clinical utility of IPA-RCP.CONCLUSIONS
IPA-RCP might provide better cerebral protection than
cRCP during aortic arch surgery under HCA.ery c March 2013
TABLE 4. Decline ratio of rSO2
Measurement point (min) cRCP (%) IPA-RCP (%) P value
10 .0004
Mean  SD 8.65  5.03 3.1  2.0
Range 0.7–18.5 0.3–6.79
20 .005
Mean  SD 12.6  6.0 6.8  3.1
Range 2.2–22.9 2.7–12.4
30 .002
Mean  SD 16.6  7.9 8.8  2.9
Range 4.2–32.4 3.1–13.9
40 .01
Mean  SD 18.8  9.6 10.7  3.3
Range 5.1–34.8 5.1–17.7
50 .01
Mean  SD 20.8  11.9 11.7  3.6
Range 7.4–44.2 6.7–18.8
60 .0004
Mean  SD 23.7  13.3 11.5  2.8
Range 7.2–52.4 7.6–18.1
70 .004
Mean  SD 24.5  13.1 13.1  3.7
Range 10.6–54.4 9.1–21.1
80 —
Mean  SD 23.1  14.8 9.7  1.4
Range 9.5–56.0 8.7–10.7
rSO2, Regional cerebral oxygen saturation; cRCP, conventional retrograde cerebral
perfusion; IPA-RCP, intermittent pressure augmented–retrograde cerebral perfusion;
SD, standard deviation.
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